NIFE
Phase 2 Completed
93 enrolled
Covered or Uncovered Bile Duct Stents
Phase NA Completed
71 enrolled
Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal
Completed
597 enrolled
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Phase 3 Completed
405 enrolled 11 charts
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Phase 1 Completed
9 enrolled
CaSSY
Phase NA Completed
261 enrolled
HPD_single
Completed
50 enrolled
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
Phase NA Completed
44 enrolled
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Phase 1 Completed
46 enrolled
Recurrence After Whipple's (RAW) Study
Completed
1,484 enrolled
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
Phase 2 Completed
28 enrolled 20 charts
TOFFEE
Phase 2 Completed
59 enrolled
EPIC-1511
Phase 3 Completed
480 enrolled
NutriGIT
Completed
66 enrolled
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Completed
722 enrolled
Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer
Phase 1 Completed
41 enrolled
AMEBICA
Phase 2/3 Completed
191 enrolled
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.
Completed
8 enrolled
Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Phase 2 Completed
39 enrolled 11 charts
TreeTopp
Phase 2/3 Completed
151 enrolled 18 charts
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer
Phase 2 Completed
62 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Phase 1 Completed
79 enrolled
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Phase 1/2 Completed
48 enrolled 13 charts
Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis
Phase NA Completed
5 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Phase 2 Completed
43 enrolled 15 charts
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
Phase 2 Completed
60 enrolled
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer
Phase 2 Completed
22 enrolled 9 charts
Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction
Phase NA Completed
58 enrolled
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase 1 Completed
28 enrolled
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
7 enrolled
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma
Phase 2 Completed
19 enrolled 8 charts
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
Phase 3 Completed
190 enrolled
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase 2 Completed
42 enrolled
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
Phase 2/3 Completed
34 enrolled
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Phase 2 Completed
39 enrolled 7 charts
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer
Phase 1 Completed
Loop-tipped Guidewire in Selective Biliary Cannulation
Phase NA Completed
200 enrolled
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
Phase 1 Completed
16 enrolled
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
Phase NA Completed
211 enrolled 9 charts
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers
Phase 1 Completed
22 enrolled
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
Phase 2 Completed
16 enrolled
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
Phase 1 Completed
36 enrolled
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
Phase 2 Completed
4 enrolled
Biological Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
24 enrolled
EPIPD
Phase 4 Completed
50 enrolled 6 charts
Interleukin-12 in Treating Patients With Cancer in the Abdomen
Phase 1 Completed
29 enrolled